Caleb J Ba Mendoza1, RaÃºl HernÃ¡ndez Rubio1, Rafael Miret1, Madeline Jacobs1, Aliu Sanni, MD, FACS2. 1Philadelphia College of Osteopathic Medicine, 2Eastside Bariatric and General Surgery LLC
Introduction: According to the National Institute of Health and the National Cancer Institute, the yearly number of new cases and deaths from gastric cancer was 7.3 /100,000 and 3.2/100,000, respectively. With a 30.6% 5-year survival rate and an estimated 10,960 new cases in 2017, finding efficient ways of management is imperative. The safety of Laparoscopic Gastrectomy (LG) for benign lesions has been proven but not yet documented in cancerous lesion management. The aim of this study was to compare clinical outcomes of LG vs. Open Gastrectomy (OG) for gastric carcinoma.
Methods and Procedures: A systematic review was conducted through PubMed to identify relevant publications between 2008-2014 that compared LG and OG. Outcomes include postoperative morbidity and mortality, intraoperative bleeding and number of harvested lymph nodes. Results are expressed as standard difference in means with standard deviation. Statistical analysis was done using fixed-effects meta-analysis to compare the mean value of the separate groups (Comprehensive Meta-Analysis Version 3.3.070 software; Biostat Inc., Englewood, NJ).
Results: Five out of 411 articles were included and assessed in this meta analysis. Among the studies, 344 patients underwent LG and 288 underwent OG. Intraoperative bleeding (0.727±0.065, p=.001) was lower in the LG group. Morbidity (OR=1.189, p=0.310), Mortality (OR=1.043, p=0.937) and Lymph Node Harvesting (0.079±0.064, p=0.214) were similar in both groups.
Conclusion: Clinical outcomes using Laparoscopic Gastrectomy is as safe and possibly superior to Open Gastrectomy for gastric cancer surgery.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 93612
Program Number: P449
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster